Video

Overcoming Racial Inequality in Epithelial Ovarian Cancer Research

Danja Sarink, PhD, discusses the importance of studying race and ethnicity in epithelial ovarian cancer research.

Danja Sarink, PhD, postdoctoral research fellow, ​Department of Cancer Epidemiology, University of Hawai’​i Cancer Center, discusses the importance of studying race and ethnicity in epithelial ovarian cancer research.

​Epithelial ovarian cancer is a rare disease and most cohort studies only have a small proportion of non-White women, making it hard to evaluate risk factors for these women in prospective studies, says Sarink.

​However, a recent study led by Sarink evaluated the incidence of epithelial ovarian cancer across different ethnic groups ​including Native Hawaiians, Japanese Americans, and Latinas.

The study found that Native Hawaiian women had an increased risk of epithelial ovarian cancer compared with Caucasian women, while Japanese Americans and Latinas had a decreased risk. Differences in risk factors, such as parity or exogenous hormone use, between racial/ethnic groups did not explain these differences in epithelial ovarian cancer risk.

As such, there ​remains a need to conduct further research in this space, Sarink concludes.

Related Videos
Julia Rotow, MD, clinical director, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute; assistant professor, medicine, Harvard Medical School
Joshua K. Sabari, MD, assistant professor, Department of Medicine, New York University Grossman School of Medicine; director, High Reliability Organization Initiatives, Perlmutter Cancer Center
Alastair Thompson, BSc, MBChB, MD, FRCS
C. Ola Landgren, MD, PhD
Sara M. Tolaney, MD, MPH
Adam M. Brufsky, MD, PhD, FACP
Justin M. Watts, MD
Sara M. Tolaney, MD, MPH
Leah Backhus, MD, MPH, FACS, professor, University Medical Line, Cardiothoracic Surgery, co-director, Thoracic Surgery Clinical Research Program, associate program director, Thoracic Track, CT Surgery Residency Training Program, Thelma and Henry Doelger Professor of Cardiovascular Surgery, Stanford Medicine; chief, Thoracic Surgery, VA Palo Alto
Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Medical Oncology, director, Center for Thoracic Cancers, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine